My interest in neuro-oncology was sparked during my undergraduate studies when I worked on a project that involved studying the effects of chemotherapy on brain tumors. The complexity of the brain and the challenges associated with treating brain tumors fascinated me. This experience solidified my passion for understanding the molecular mechanisms of brain tumors and finding innovative treatments to improve patient outcomes.

One of the most challenging projects I worked on involved developing a novel drug delivery system for brain tumors. The main obstacle was ensuring the drug could cross the blood-brain barrier effectively. Through extensive literature review and collaboration with pharmacologists, we identified a carrier molecule that improved drug penetration. This experience taught me the importance of interdisciplinary collaboration and persistence in overcoming research challenges.

I stay updated by regularly attending international conferences, such as the Society for Neuro-Oncology Annual Meeting, and participating in webinars and workshops. Additionally, I subscribe to leading journals like 'Neuro-Oncology' and 'Cancer Research' to keep abreast of the latest studies and methodologies. Networking with peers and mentors in the field also provides valuable insights and keeps me informed about emerging trends.

Interdisciplinary collaboration is crucial in neuro-oncology research as it brings together experts from various fields such as neurology, oncology, pharmacology, and bioengineering. This collaborative approach allows for a more comprehensive understanding of brain tumors and fosters the development of innovative treatments. For instance, combining insights from molecular biology with clinical expertise can lead to more effective therapeutic strategies and better patient care.

Ethical considerations are paramount in research involving human subjects. I ensure that all studies are conducted in accordance with institutional review board (IRB) guidelines and that informed consent is obtained from participants. Transparency and respect for participants' rights are non-negotiable. I also advocate for the inclusion of diverse populations to ensure that research findings are applicable to a broader patient base, thereby promoting equity in healthcare.